Home » Topics » BioWorld

BioWorld
RSS

Regenerons CNTF Designated Orphan Drug

Feb. 11, 1992

MEDICORP ACQUIRES TECHNOLOGY RIGHTS

Feb. 11, 1992

FDA APPROVES ONCOR CANCER DIAGNOSTIC

Feb. 11, 1992

IMMUNE RESPONSE CONSIDERS COLLABORATION

Feb. 10, 1992

TREATMENT FOR HYPOTENSIVE DIZZINESS

Feb. 10, 1992

ONCOR UNDERWRITERS EXERCISE OPTION

Feb. 10, 1992

CEL-SCI RAISES $14 MILLION IN OFFERING

Feb. 10, 1992

CYGNUS PREPARES FOR MARKET

Feb. 10, 1992

IVAX UNIT LICENSES CHEMOPROTECTIVE

Feb. 10, 1992

IMMUNEX DOWN ON NEGATIVE COMMENTS

Feb. 10, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...